SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001144204-13-009561
Filing Date
2013-02-15
Accepted
2013-02-15 11:50:12
Documents
1
Group Members
DON A. SANDERSJAMES C. GALELIFE SCIENCES OPPORTUNITIES FUND II (INSTITUTIONAL), L.P.SIGNET HEALTHCARE PARTNERS, LLCSMW INVESTMENTS I, LLCSOF MANAGEMENT, LLC

Document Format Files

Seq Description Document Type Size
1 AMENDMENT TO SCHEDULE 13D v335384_sc13da.htm SC 13D/A 166317
  Complete submission text file 0001144204-13-009561.txt   168191
Mailing Address 7180 SW SANDBURG STREET, SUITE 100 TIGARD OR 97223
Business Address 7180 SW SANDBURG STREET, SUITE 100 TIGARD OR 97223 503-692-8001
BIOJECT MEDICAL TECHNOLOGIES INC (Subject) CIK: 0000810084 (see all company filings)

IRS No.: 931099680 | State of Incorp.: OR | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-40150 | Film No.: 13618172
SIC: 3841 Surgical & Medical Instruments & Apparatus

Mailing Address 126 E 56TH STREET 28TH FL NEW YORK NY 10022
Business Address 126 EAST 56TH STREET NEW YORK NY 10022 212-419-3900
LIFE SCIENCES OPPORTUNITIES FUND II LP (Filed by) CIK: 0001269415 (see all company filings)

IRS No.: 571190948 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A